天目药业
(600671)
| 流通市值：23.20亿 | | | 总市值：23.21亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 44,388,576.68 | 211,753,756.64 | 158,940,412.66 | 103,597,373.91 |
| 营业收入 | 44,388,576.68 | 211,753,756.64 | 158,940,412.66 | 103,597,373.91 |
| 二、营业总成本 | 39,629,817.55 | 202,114,934.39 | 149,050,601.43 | 100,327,240.73 |
| 营业成本 | 20,083,404.99 | 110,612,906.03 | 85,227,696.11 | 59,951,092.44 |
| 税金及附加 | 558,010.84 | 2,561,943.09 | 1,850,426.12 | 1,109,218.65 |
| 销售费用 | 3,473,662.92 | 13,454,395.14 | 10,165,110.27 | 6,399,486.78 |
| 管理费用 | 13,947,158.25 | 68,396,562.41 | 46,836,705.48 | 29,653,362.27 |
| 财务费用 | 1,567,580.55 | 7,089,127.72 | 4,970,663.45 | 3,214,080.59 |
| 其中:利息费用 | 1,559,259.55 | 7,198,209.47 | 5,051,561.39 | 3,257,961.5 |
| 其中:利息收入 | 300.53 | 138,604.59 | 82,941.43 | 59,278.96 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | 1,708,564.94 | 3,993.35 | 3,993.35 |
| 资产处置收益 | - | 366,510.98 | 299,864.55 | -614,970.43 |
| 资产减值损失(新) | - | -1,657,052.82 | -604,734.79 | -494,501.47 |
| 信用减值损失(新) | -408,923.29 | -2,102,766.51 | -2,726,517.05 | 293,545.27 |
| 其他收益 | 177,379.02 | 438,647.84 | 291,106.67 | 190,492.83 |
| 四、营业利润 | 4,527,214.86 | 8,392,726.68 | 7,153,523.96 | 2,648,692.73 |
| 加:营业外收入 | 1,451,288.21 | 7,952,584.42 | 6,500,620.8 | 4,619,205.46 |
| 减:营业外支出 | 44,173.64 | 6,120,919.78 | 3,652,956.02 | 149,157.34 |
| 五、利润总额 | 5,934,329.43 | 10,224,391.32 | 10,001,188.74 | 7,118,740.85 |
| 减:所得税费用 | 2,844,339.73 | 3,021,446.15 | 2,493,114.95 | 720,910.42 |
| 六、净利润 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 | 6,397,830.43 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 | 6,397,830.43 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,816,104.36 | 17,622,617.59 | 14,208,796.6 | 10,247,808.74 |
| 少数股东损益 | -726,114.66 | -10,419,672.42 | -6,700,722.81 | -3,849,978.31 |
| 扣除非经常损益后的净利润 | 2,265,284.42 | 13,470,505.09 | 10,882,970.33 | 5,903,269.48 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.03 | 0.14 | 0.12 | 0.08 |
| (二)稀释每股收益 | 0.03 | 0.14 | 0.12 | 0.08 |
| 九、综合收益总额 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 | 6,397,830.43 |
| 归属于母公司股东的综合收益总额 | 3,816,104.36 | 17,622,617.59 | 14,208,796.6 | 10,247,808.74 |
| 归属于少数股东的综合收益总额 | -726,114.66 | -10,419,672.42 | -6,700,722.81 | -3,849,978.31 |
| 公告日期 | 2026-04-30 | 2026-04-18 | 2025-10-29 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |